| Species |
Human |
| Protein Construction |
XPNPEP2 (His22-Ala649)_x000D_
Accession # O43895 |
His |
| N-term |
C-term |
|
| Purity |
> 95% as determined by BisTris PAGE
> 95% as determined by HPLC |
| Endotoxin Level |
Less than 1EU per μg by the LAL method. |
| Biological Activity |
Measured by its ability to cleave the fluorogenic peptide substrate, HLys(2Aminobenzoyl)ProPropNitroanilide (K(Abz)PPpNA). The specific activity is > 300 pmol/min/µg. Test result meets the standard |
| Expression System |
HEK293 |
| Theoretical Molecular Weight |
71.83 kDa |
| Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 73-83 kDa based on Bis-Tris PAGE result. |
| Formulation |
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). |
| Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
| Target Background |
Aminopeptidase P2 (XPNPEP2) is a receptor for TMTP1 tumor-homing peptide. However, the biological and clinical significance of Aminopeptidase P2 in human cancers remains unknown. |
| Synonyms |
Xpnpep2 ; Xaa-Pro aminopeptidase 2; Aminoacylproline aminopeptidase; X-Pro aminopeptidase 2 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
